Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

1. Bellmunt, J.
2. Hussain, M.
3. Gschwend, J.E.
4. Albers, P.
5. Oudard, S.
6. Castellano, D.
7. Daneshmand, S.
8. Nishiyama, H.
9. Majchrowicz, M.
10. Degaonkar, V.
11. Shi, Y.
12. Mariathasan, S.
13. Grivas, P.
14. Drakaki, A.
15. O'Donnell, P.H.
16. Rosenberg, J.E.
17. Geynisman, D.M.
18. Petrylak, D.P.
19. Hoffman-Censits, J.
20. Bedke, J.
21. Kalebasty, A.R.
22. Zakharia, Y.
23. van der Heijden, M.S.
24. Sternberg, C.N.
25. Davarpanah, N.N.
26. Powles, T.
27. Mostrar todos los/as autores/as +